EUR 3.61
(0.26%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 317.79 Thousand EUR | 10.11% |
2022 | 288.6 Thousand EUR | 103.12% |
2021 | 142.08 Thousand EUR | 175.51% |
2020 | 51.57 Thousand EUR | 125.48% |
2019 | 22.87 Thousand EUR | -68.35% |
2018 | 72.25 Thousand EUR | 72.03% |
2017 | 42 Thousand EUR | 524937.5% |
2016 | 8.00 EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 FY | 317.79 Thousand EUR | 10.11% |
2023 Q4 | 142.97 Thousand EUR | 0.0% |
2023 Q2 | 164.82 Thousand EUR | 0.0% |
2022 Q2 | 151.47 Thousand EUR | 0.0% |
2022 FY | 288.6 Thousand EUR | 103.12% |
2022 Q4 | 137.12 Thousand EUR | 0.0% |
2021 Q2 | 39.21 Thousand EUR | 0.0% |
2021 FY | 142.08 Thousand EUR | 175.51% |
2021 Q4 | 102.86 Thousand EUR | 0.0% |
2020 Q2 | 24.4 Thousand EUR | 0.0% |
2020 Q4 | 27.16 Thousand EUR | 0.0% |
2020 FY | 51.57 Thousand EUR | 125.48% |
2019 Q4 | 11.03 Thousand EUR | 0.0% |
2019 FY | 22.87 Thousand EUR | -68.35% |
2019 Q2 | 11.84 Thousand EUR | 0.0% |
2018 Q2 | 57.64 Thousand EUR | 219.12% |
2018 Q1 | 18.06 Thousand EUR | -51.72% |
2018 FY | 72.25 Thousand EUR | 72.03% |
2018 Q4 | -40.76 Thousand EUR | 0.0% |
2017 Q2 | 10.5 Thousand EUR | 0.0% |
2017 Q4 | 37.41 Thousand EUR | 0.0% |
2017 Q1 | 10.5 Thousand EUR | 0.0% |
2017 FY | 42 Thousand EUR | 524937.5% |
2016 FY | 8.00 EUR | 0.0% |
2016 Q4 | 10.5 Thousand EUR | 0.0% |
2016 Q2 | 2.00 EUR | 0.0% |
2016 Q1 | 2.00 EUR | 0.0% |
2015 Q4 | 2.00 EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Biosynex SA | 92.97 Million EUR | 99.658% |
bioMérieux S.A. | 3.67 Billion EUR | 99.991% |
Eurofins Scientific SE | 6.51 Billion EUR | 99.995% |
Lumibird SA | 203.55 Million EUR | 99.844% |